Coronavirus updates: Oxford vaccine shows promise; Europe sees decline in new cases; pork plant managers bet on number of infections
After a long struggle with Covid-19, there seems to be the hope of a vaccine that should be available in the future. This new vaccine was taken to a judge panel, and according to their results, should be able to put an end to Covid-19 earlier than their’ previous estimate in June. This is great news for many people, as the vaccine is already undergoing phase Ⅲ trials, which means that the correct dosage has been figured out, and now it is testing for effectiveness in over 30,000 volunteers. Vaccine candidates from Moderna and Pfizer/BioNTech are in phase Ⅲ testing as well. Phase 2 of the vaccine candidate tests for dosage, and if it will help the most vulnerable people, such as the elderly. This vaccine from Astra-Zeneca seems to trigger a robust immune response in healthy adults, especially those aged 56 and over. These vaccines show serious promise, with 90-95% effectiveness in the tested age groups. This is great news for anyone, as these vaccines were not expected to come as early as they did. These vaccine candidates are still going through trials, but they are something to look forward to in the future. Although these vaccines still need to be mass-produced and delivered, some of these vaccines are expected to be delivered in the upcoming weeks.
This article is very positive and informative, and it is really something to look forward to. A vaccine coming out for the general public in the near future will be a huge improvement over the current situation. With all these new vaccine candidates coming out, the end of Covid-19 seems to be getting closer and closer.